Abstract
A versatile core structure has been prepared that should provide a foundation for the syntheses of the hetidine and hetisine type of diterpenoid alkaloids. The synthesis of the caged polycyclic core structure, which features nine contiguous stereocenters, utilizes a Ga(III)-catalyzed cycloisomerization of alkynyl indenes as well as a Michael/aldol sequence to build the bicyclo-[2.2.2] framework.
Keywords: Diterpenoid alkaloids, Hetidine, Hetisine, catalysis, gallium, oxidative dearomatization
The diterpenoid alkaloids comprise over 1100 natural products of daunting architectural complexity bearing a vast array of hydroxylation patterns.i The potent interactions of these molecules with voltage-gated ion channels, which lead to a broad spectrum of bioactivity, is well-recognized.ii Biological activities including acetylcholinesterase inhibition, as well as analgesic, anti-inflammatory, myorelaxant and anti-arrhythmic properties have been reported for many members of this family.iii Furthermore, many of the plants that produce diterpenoid alkaloid natural products are used as sedatives and fever reducers, along with many other uses.iv As a result of their complex structures, as well as emerging interest in their use to address problems in cognitive decline, there has been a veritable renaissance in the chemical syntheses of the diterpenoid alkaloids. Our approach to the construction of these natural products centers on the goal of identifying a versatile late-stage intermediate that could be applicable to the syntheses of several members of this family, especially, the hetidines (e.g., navirine, 1, Figure 1), for which no syntheses are known. In this Communication, we report our progress toward this goal, which has resulted in the synthesis of an advanced tetracycle that we believe sets the stage for the syntheses of natural products in the hetidine and hetisine structural classes (e.g., 1, and kobusine, 2, respectively).
Figure 1.
Selected hetidine and hetisine diterpenoid alkaloids
Although no previous syntheses of molecules in the hetidine structural class have been reported to date, there has been substantial effort dedicated to the synthesis of the hetisine diterpenoid alkaloids. Most of these approaches, which were aimed at the synthesis of a single target,v are exemplified by the preparation of nominine (3) by Natsume and Muratake in 2004vi and by Gin and Peese’s highly efficient synthesis in 2006 using a beautifully orchestrated dipolar cycloaddition/[4+2] cycloaddition strategy.vii In our analysis of the hetidine and hetisine frameworks, we recognized that a fused 6-7-6 carbocyclic motif (see bolded bonds in A, Figure 1) was conserved and could therefore serve productively as a common late stage structure for the construction of these related natural products. In a key chemical transformation that would link these two structural classes, we envisioned the hetisine skeleton (see B) arising from the hetidine framework (A) using a formally dehydrogenative C-N bond formation reaction. The successful use of the Hoffman-Löffler-Freytag reaction to accomplish an analogous transformation has been previously reported by Okamoto and coworkers, albeit in modest yield.viii
On the basis of the analysis presented above, we selected the general structure 4 (Scheme 1) as our initial target. This advanced intermediate, which reflects the hetidine skeleton, is at an intermediate oxidation level that makes it well-suited as a precursor to many hetidine and hetisine diterpenoid alkaloids including navirine (1) and kobusine (2). The bicyclo[2.2.2] portion of 4 could arise from methoxy arene 5. To date, the most expedient route to convert methoxybenzene derivatives related to 5 to the [2.2.2]-bicyclic substructure can be found in the work of Gin and Peese,vii which exploits an intramolecular [4+2] cycloaddition. Several recent syntheses of kaurane type diterpenoids have proceeded along similar lines.ix As such, we imagined that this tactic or a variant could, in principle, be employed to transform tetracycle 5 to advanced polycycle 4. The bridging framework of 5 could be simplified to benzannulated cycloheptadiene 6, which would arise from indenyl alkyne 7 using a Ga(III)-catalyzed cycloisomerization transformation that has been developed in our groupx and previously exploited by us in the syntheses of natural products in the icetexane diterpenoid family.xi
Scheme 1.
Retrosynthetic analysis of common late-stage intermediate general structure 4
Our chemical synthesis of general structures related to 4 began with the preparation of tricycle 12 (Scheme 2) using known iodo-alkyne 8 (9 steps from commercially available 3-bromopropan-1-ol),xii and commercially available β-ketoester 9.xiii, xiv A standard alkylation using K2CO3 afforded the adduct of 8 and 9, which, following saponification and decarboxylation, provided indanone 10 in 76% yield over the two steps. Selective reduction of the carbonyl group of 10, which proceeded uneventfully in the presence of the nitrile group, and elimination of the resulting hydroxyl yielded indene 7. Cycloisomerization of 7 using catalytic Ga(III) iodide under conditions we have previously established gave benzannulated cycloheptadiene 6 (see Scheme 1), which, following selective reduction of the disubstituted double bond using diimide, gave 11. Oxygenation of the doubly activated allylic and benzylic methylene group of 11 was achieved upon brief exposure to cerric ammonium nitrate (CAN) adsorbed on silica to yield an enone (not shown). Hydrogenation of the enone proceeded with high levels of diastereocontrol to give 12, the structure of which was confirmed by single crystal X-ray analysis (see ORTEP). The remarkable diastereoselectivity of this hydrogenation reaction is not well understood at this time and we are working to gain more insight into the selectivity of this process.xv Tricycle 12 represents the key 6-7-6 substructure that is conserved in the hetidine and hetisine diterpenoid alkaloid families (see A, Figure 1).
Scheme 2.
Synthesis of tricycle 12: a) K2CO3, acetone, 65 °C, 18 h 76%; b) LiOH•H2O, THF:H2O (4:1), 65 °C, 98%; c) NaBH4, EtOH, 0 °C; d) PPTS, benzene, 80 °C, 70% (over 2 steps); e) GaI3 (25 mol%), 4 Å MS, toluene, 100 °C, 48 h, 89%; f) Et3N, TsNHNH2, 1,2-DCE, 65 °C, 83%; g) CAN on silica, CH2Cl2:H2O (4:1), 0 °C, 5 min, 52%; h) H2 (1 atm), 5 wt% Pd/C, EtOAc, quantitative.
THF = tetrahydrofuran, PPTS = pyridinium para-toluene sulfonate, MS = molecular sieves, DCE = dichloroethane, CAN = cerric ammonium nitrate.
Allylation of ketone 12 using NaH and allyl bromide (see Scheme 3) resulted in a mixture of O- and C-allyl products which converged to a single diastereomer of the C-allylated compound (13) via a Claisen rearrangement upon heating to 160 °C (microwave). Reduction of ketone 13 with LAH yielded an amino alcohol as a single diastereomer,xvi which upon selective Boc-protection of the amino group yielded 14. Exposure of carbamate alcohol 14 to thionyl chloridexvii effected cyclization to form 5, where the piperidine ring has been installed.xviii The structure of 5 was unambiguously confirmed by X-ray crystallographic analysis of the corresponding 4-nitrobenzamide derivative (15).
Scheme 3.
Synthesis of tetracycle 5: a) NaH, allyl bromide, DMF, 50 °C, 45 min; b) DMF, 160 °C (microwave), 45 min, 69% (over 2 steps); c) LAH, THF, 65 °C, 4 h; d) Boc2O, Et3N, CH2Cl2, 23 °C, 92% (over 2 steps); e) SOCl2, CH2Cl2, 23 °C, 1 h, 72%. DMF = dimethylformamide, LAH = lithium aluminum hydride, Boc = tert-butoxy carbonyl.
Access to 5 set the stage for the exploration of various tactics to install the bicyclo-[2.2.2] portion of the hetidines and hetisines, which we envisioned would involve a dearomatization of the arene moiety. Our early attempts, which proved unfruitful, sought to proceed by the Birch reduction of methoxybenzene 5. However, the resulting dihydrobenzene reduction product was unstable and could not be easily advanced. We were ultimately drawn to oxidative dearomatizations, which could site selectively introduce oxygenation at C14 (see 18, Scheme 4) and would be advantageous for the synthesis of navirine (1) and related alkaloids. Thus, cleavage of the methyl ether in 5 afforded phenol 16 in 85% yield. Oxidative dearomatization of 16 using phenyliodine bistrifluoroacetate (PIFA; a.k.a [bis(trifluoroacetoxy)iodo]benzene) yielded cyclohexadienone 18 in 54% yield via the presumed intermediacy of 17.xix To the best of our knowledge, this is the first example of enlisting a Boc carbamate as a nucleophile in an oxidative dearomatization reaction. Dihydroxylation/periodate cleavagexx of the allyl group in 18 yielded aldehyde 19, which upon stirring with silica gel gave the Michael addition product 20. At this stage, reduction of the enone double bond and treatment of the resulting ketone aldehyde with K2CO3 in methanol led to aldol cyclization to provide 4a. The structure of 4a was unambiguously secured by X-ray crystallographic analysis.
Scheme 4.
Synthesis of 4a, a common late-stage intermediate for the hetidines and hetisines: a) NaH, EtSH, DMF, 180 °C (microwave), 15 min), 85%; b) PIFA (1.5 equiv), MeCN: CF3CH2OH (1:1), 0 °C, 54%; c) cat. OsO4, NMO, THF:H2O (2:1), 23 °C, 5 days; d) NaIO4 on silica, CH2Cl2, 23 °C, 30 min, 59% (over 2 steps); e) SiO2, CH2Cl2, 36 h, 80%; f) H2, 5 wt% Rh/Al2O3 (50 wt%), benzene, 24 h; g) K2CO3 (10 equiv), MeOH: CH2Cl2 (9:1), 4 h, 43% (over 2 steps). DMF = dimethylformamide, PIFA = phenyliodine bis(trifluoroacetate), MeCN = acetonitrile, NMO = N-methylmorpholine N-oxide.
The synthesis of 4a addresses many of the significant challenges inherent in the synthesis of the hetidine and hetisine diterpenoid alkaloids. This includes the introduction of nine contiguous stereocenters (3 of which are quaternary) and the construction of a highly caged, bridged ring system. Our approach reinforces the significance of our recognition of the 6-7-6 ring system as an important starting point for the synthesis of the diterpenoid alkaloids. Key to the success of our outlined plan thus far is the use of a Ga(III)-catalyzed cycloisomerization reaction for the synthesis of the 6-7-6 tricycle, a remarkably diastereoselective hydrogenation that effectively distinguishes between a methyl and nitrile group, and an unusual oxidative dearomatization reaction involving a Boc carbamate to initiate the construction of the bicyclo-[2.2.2] framework. Despite these advances, several challenges, including the selective manipulation of the bicyclo[2.2.2] framework (i.e., removing the hydroxy group or converting the ketone group to an exo-methylene) lie ahead. Studies to implement these planned synthetic steps, as well as related efforts to apply 4a to the syntheses of hetidine and hetisine alkaloids including navirine and kobusine are the focus of our current studies.
Supplementary Material
Acknowledgments
The work was supported by a grant from the NIH USA (NIGMS RO1 084906). FJC is grateful to the NIH USA for a graduate award (F31 GM089139) and DL thanks the FQNRT Canada for a postdoctoral fellowship. RS is a Camille-Dreyfus Teacher Scholar, Alfred P. Sloan Fellow and acknowledges unrestricted support from Abbott, Eli Lilly, Astra Zeneca and Aldrich.
Footnotes
Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.
References
- i.(a) Wang F-P, Liang X-T. Alkaloids. 2002;59:1–280. doi: 10.1016/s0099-9598(02)59008-8. [DOI] [PubMed] [Google Scholar]; (b) Wang F-P, Chen Q-H, Liu X-Y. Nat. Prod. Rep. 2010;27:529–570. doi: 10.1039/b916679c. [DOI] [PubMed] [Google Scholar]
- ii.(a) Ameri A. Prog. Neurobiol. 1998;56:211–235. doi: 10.1016/s0301-0082(98)00037-9. [DOI] [PubMed] [Google Scholar]; (b) Friese J, Gleitz J, Gutser UT, Heubach JF, Matthiesen T, Wilffert B, Selve N. Eur. J. Pharmacol. 1997;337:165–174. doi: 10.1016/s0014-2999(97)01268-5. [DOI] [PubMed] [Google Scholar]; (c) Triggle DJ, Gopalakrishnan M, Rampe D, Zheng W. Voltage-Gated Ion Channels as Drug Targets. vol. 29. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006. pp. 1–479. [Google Scholar]
- iii.For a description of the bioactivities of these compounds, see Ref. i.
- iv.Anger T, Madge DJ, Mulla M, Riddall D. J. Med. Chem. 2001;44:115–137. doi: 10.1021/jm000155h. [DOI] [PubMed] [Google Scholar]; (b) Ref. 1b provides an excellent summary of these medicinal applications.
- v.(a) Somei M, Okamoto T. Chem. Pharm. Bull. 1970;18:2135–2138. [Google Scholar]; (b) van der Baan JL, Bickelhaupt F. Recl. Trav. Chim. Pays-Bas. 1975;94:109–112. [Google Scholar]; (c) Shibanuma Y, Okamoto T. Chem. Pharm. Bull. 1985;33:3187–3194. [Google Scholar]; (d) Kwak Y, Winkler JD. J. Am. Chem. Soc. 2001;123:7429–7430. doi: 10.1021/ja010542w. [DOI] [PubMed] [Google Scholar]; (e) Muratake H, Natsume M. Tetrahedron Lett. 2002;43:2913–2917. [Google Scholar]; (f) Williams CM, Mander LN. Org. Lett. 2003;5:3499–3502. doi: 10.1021/ol0353060. [DOI] [PubMed] [Google Scholar]; (g) Peese KM, Gin DY. Org. Lett. 2005;7:3323–3325. doi: 10.1021/ol051184v. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Williams CM, Mander LN, Bernhardt PV, Willis AC. Tetrahedron. 2005;61:3759–3769. [Google Scholar]; (i) Hutt OE, Mander LN. J. Org. Chem. 2007;72:10130–10140. doi: 10.1021/jo701995u. [DOI] [PubMed] [Google Scholar]
- vi.(a) Muratake H, Natsume M. Angew. Chem. Int. Ed. 2004;43:4646–4649. doi: 10.1002/anie.200460332. [DOI] [PubMed] [Google Scholar]; (b) Muratake H, Natsume M. Tetrahedron. 2007;62:7056–7070. [Google Scholar]; (c) Muratake H, Natsume M. Tetrahedron. 2007;62:7071–7092. [Google Scholar]; (d) Muratake H, Natsume M. Tetrahedron. 2007;62:7093–7112. [Google Scholar]
- vii.(a) Peese KM, Gin DY. J. Am. Chem. Soc. 2006;128:8734–8735. doi: 10.1021/ja0625430. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Peese KM, Gin DY. Chem. Eur. J. 2008;14:1654–1665. doi: 10.1002/chem.200701290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- viii.Yatsunami T, Isono T, Hayakawa I, Okamoto T. Chem. Pharm. Bull. 1975;23:3030–3032. [Google Scholar]
- ix.(a) Gong J, Lin G, Sun W, Li C-C, Yang Z. J. Am. Chem. Soc. 2010;132:16745–16746. doi: 10.1021/ja108907x. [DOI] [PubMed] [Google Scholar]; (b) Liu X-Y, Cheng H, Li X-H, Chen Q-H, Xu L, Wang F-P. Org. Biomol. Chem. 2012;10:1411–1417. doi: 10.1039/c1ob06704d. [DOI] [PubMed] [Google Scholar]
- x.Simmons EM, Sarpong R. Org. Lett. 2006;8:2883–2886. doi: 10.1021/ol061037c. [DOI] [PubMed] [Google Scholar]
- xi.(a) Simmons EM, Yen JR, Sarpong R. Org. Lett. 2007;9:2705–2708. doi: 10.1021/ol0712428. [DOI] [PubMed] [Google Scholar]; (b) de J. Cortez F, Sarpong R. Org. Lett. 2010;12:1428–1431. doi: 10.1021/ol902959v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- xii.See Ref. (Jesse’s paper)
- xiii.House HO, Hudson CB. J .Org. Chem. 1970;35:647–651. [Google Scholar]
- xiv.Of note, the lone stereocenter in 8 may be introduced in enantioenriched form using the enantioselective Rh-catalyzed conjugate addition protocol of Ito ( Sawamura M, Hamashima H, Ito Y. Tetrahedron. 1994;50:4439–4454. Sawamura M, Hamashima G, Shinoto H, Ito Y. Tetrahedron Lett. 1995;36:6479–6482. ) which will set the stage for an enantioselective synthesis of our targets by employing subsequent diastereoselective processes.
- xv.The observed diastereoselectivity may be rationalized by torsional steering. For a review, see: Houk KN, Tucker JA, Dorigo AE. Acc. Chem. Res. 1990;23:107–113.
- xvi.The sense of diastereoselectivity, which is inconsequential, was not determined.
- xvii.Xu F, Simmons B, Reamer RA, Corley E, Murry J, Tschaen D. J. Org. Chem. 2008;73:312–315. doi: 10.1021/jo701877h. [DOI] [PubMed] [Google Scholar]
- xviii.The efficiency of this step may be attributed to the possible formation of a stabilized benzylic carbocation intermediate.
- xix.For pertinent reviews on dearomatization processes see: Roche SP, Porco JA., Jr Angew. Chem. Int. Ed. 2011;50:4068–4094. doi: 10.1002/anie.201006017. Magdziak D, Meek SJ, Pettus TRR. Chem. Rev. 2004;104:1383–1429. doi: 10.1021/cr0306900.
- xx.Zhong Y-L, Shing TKM. J. Org. Chem. 1997;62:2622–2624. doi: 10.1021/jo9621581. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





